Everolimus-Eluting Stent (Espalier) in Coronary Artery Revascularization: A Retrospective, Investigator-Initiated, Multicenter Study

Parminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari · 2026

Read Everolimus-Eluting Stent (Espalier) in Coronary Artery Revascularization: A Retrospective, Investigator-Initiated, Multicenter Study by Parminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278689.txt.

Description

Parminder Singh Manghera and colleagues report real-world results for an everolimus-eluting heart stent in a 2026 multicentre study. Drug-eluting stents prop open narrowed coronary arteries during angioplasty. The Espalier stent, made in India, was assessed for safety and performance in routine practice.

Records covered 402 adults treated at tertiary centres, followed for twelve months. Device placement and the overall procedure succeeded in every case. Serious target-lesion events stayed rare at one year, and no heart attacks or stent clots occurred. Older patients and those with unstable symptoms or multiple conditions ran higher risks. The authors present the device as effective in everyday Indian practice.

Catalog record

CREATORParminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13278689

Browse the full library · About the Tower of Babel